Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Patent 11891365 was granted and assigned to Valo Health on February, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David S. Millan0

Cuixian Liu0

Matthew W. Martin0

Heather Davis0

David R. Lancia, Jr.0

Kenneth W. Bair0

Xiaozhang Zheng0

Jennifer R. Thomason0

...

Date of Patent

February 6, 2024

0

Patent Application Number

172383210

Date Filed

April 23, 2021

0

Patent Citations

US Patent 7214690 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods

0

US Patent 7241775 Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines

0

US Patent 7495111 Compounds useful as serotonin inhibitors and 5-HT

0

US Patent 7582667 Dihydrospiro[dibenzo[a,d][7]annulene-5,4′-imidazol] compounds for the inhibition of beta-secretase

0

US Patent 7622582 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one

0

US Patent 7704756 Fluorogenic dyes

0

US Patent 7705017 Compounds for treatment of neurodegenerative diseases

0

US Patent 7723349 Aza spiro alkane derivatives as inhibitors of metalloproteases

0

...

Patent Primary Examiner

Brenda L Coleman

0

CPC Code

0

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool